Genetic predisposition to lung cancer: Comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Wang, Junjun ^a   Liu, Qingyun ^a   Yuan, Shuai ^a   Xie, Weijia ^a   Liu, Yuan ^a   Xiang, Ying ^a   Wu, Na ^a   Wu, Long ^a   Ma, Xiangyu ^a   Cai, Tongjian ^a   Zhang, Yao ^a   Sun, Zhifu ^b   Li, Yafei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN; LUNG TUMOR; META ANALYSIS; RISK ASSESSMENT;

GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; RISK ASSESSMENT;

EID: 85027875413     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-07737-0     Document Type: Article

References (53)

1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359-386, doi:10.1002/ijc.29210 (2015).
2. World Health Organization & International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. Vol. 83 166-167 (IARC, 2004).
3. Brownson, R. C., Alavanja, M. C., Caporaso, N., Berger, E. & Chang, J. C. Family history of cancer and risk of lung cancer in lifetime non-smokers and long-term ex-smokers. Int J Epidemiol 26, 256-263 (1997).
4. Bailey-Wilson, J. E. et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am. J. Hum. Genet. 75, 460-474, doi:10.1086/423857 (2004).
5. You, M. et al. Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin. Cancer Res. 15, 2666-2674, doi:10.1158/1078-0432.ccr-08-2335 (2009).
6. Musolf, A. M. et al. Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies. Genes 8, doi:10.3390/ genes8010036 (2017).
7. Ku, C. S., Loy, E. Y., Pawitan, Y. & Chia, K. S. The pursuit of genome-wide association studies: where are we now&quest. J. Hum. Genet. 55, 195-206 (2010).
8. Wang, Y. et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet. 40, 1407-1409, doi:10.1038/ng.273 (2008).
9. Broderick, P. et al. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 69, 6633-6641, doi:10.1158/0008-5472.can-09-0680 (2009).
10. Hung, R. J. et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452, 633-637, doi:10.1038/nature06885 (2008).
11. Shiraishi, K. et al. A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat. Genet. 44, 900-903, doi:10.1038/ng.2353 (2012).
12. Wu, C. et al. Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res. 69, 5065-5072, doi:10.1158/0008-5472.can-09-0081 (2009).
13. Yoon, K. A. et al. A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum. Mol. Genet. 19, 4948-4954, doi:10.1093/hmg/ddq421 (2010).
14. Wang, M. et al. Genetic variant in DNA repair gene GTF2H4 is associated with lung cancer risk: a large-scale analysis of six published GWAS datasets in the TRICL consortium. Carcinogenesis. doi:10.1093/carcin/bgw070 (2016).
15. Timofeeva, M. N. et al. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum. Mol. Genet. 21, 4980-4995, doi:10.1093/hmg/dds334 (2012).
16. Brennan, P., Hainaut, P. & Boffetta, P. Genetics of lung-cancer susceptibility. Lancet Oncol 12, 399-408, doi:10.1016/s1470-2045(10)70126-1 (2011).
17. Bertram, L., McQueen, M. B., Mullin, K., Blacker, D. & Tanzi, R. E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39, 17-23, doi:10.1038/ng1934 (2007).
18. Zhang, B., Beeghly-Fadiel, A., Long, J. & Zheng, W. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 12, 477-488, doi:10.1016/s1470-2045(11)70076-6 (2011).
19. Ma, X., Zhang, B. & Zheng, W. Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, metaanalysis, and epidemiological evidence. Gut 63, 326-336, doi:10.1136/gutjnl-2012-304121 (2014).
20. Little, J. et al. The HuGENet™ HuGE review handbook, version 1.0. Ottawa, Ontario, Canada: HuGENet Canada Coordinating Centre (2006).
21. Ioannidis, J. P. A. et al. Assessment of cumulative evidence on genetic associations: interim guidelines. International journal of epidemiology 37, 120-132, doi:10.1093/ije/dym159 (2008).
22. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Grp, P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann. Intern. Med. 151, 264-W264 (2009).
23. Landi, M. T. et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet. 85, 679-691, doi:10.1016/j.ajhg.2009.09.012 (2009).
24. Hu, Z. et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat. Genet. 43, 792-796, doi:10.1038/ng.875 (2011).
25. Ward, L. D. & Kellis, M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 44, D877-881, doi:10.1093/nar/gkv1340 (2016).
26. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat Methods 7, 248-249, doi:10.1038/ nmeth0410-248 (2010).
27. Zienolddiny, S. & Skaug, V. Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer. Lung Cancer Targets Ther 3, 1-14 (2012).
28. Lo, Y. L. et al. A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 18, 223-229 (2009).
29. Xiao, M., Chen, L., Wu, X. & Wen, F. The association between the rs6495309 polymorphism in CHRNA3 gene and lung cancer risk in Chinese: a meta-analysis. Sci. Rep. 4, 6372, doi:10.1038/srep06372 (2014).
30. Ryan, B. M. et al. Identification of a functional SNP in the 3′UTR of CXCR2 that is associated with reduced risk of lung cancer. Cancer Res. 75, 566-575 (2015).
31. Acosta, J. C. et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006-1018 (2008).
32. Hunt, R., Sauna, Z. E., Ambudkar, S. V., Gottesman, M. M. & Kimchi-Sarfaty, C. Silent (synonymous) SNPs: should we care about them? Methods Mol. Biol. 578, 23-39, doi:10.1007/978-1-60327-411-1-2 (2009).
33. Mogi, A. & Kuwano, H. TP53 mutations in nonsmall cell lung cancer. J Biomed Biotechnol 2011, 583929, doi:10.1155/2011/583929 (2011).
34. Lind, H. et al. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer. Cancer Epidemiol Biomarkers Prev 16, 2077-2081, doi:10.1158/1055-9965.epi-07-0153 (2007).
35. Wang, J., Yu, W., Cai, Y., Ren, C. & Ittmann, M. M. Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression. Neoplasia 10, 847-856 (2008).
36. Sutton, A. et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet. Genomics 15, 311-319 (2005).
37. Zhang, Y. et al. Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer: A case-control study in northeast Chinese male population. Med. Oncol. 31 (2014).
38. Rafnar, T. et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet. 41, 221-227, doi:10.1038/ng.296 (2009).
39. Torruella-Loran, I. et al. MicroRNA Genetic Variation: From Population Analysis to Functional Implications of Three Allele Variants Associated with Cancer. Hum. Mutat. 37, 1060-1073, doi:10.1002/humu.23045 (2016).
40. Hu, Z. et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. The Journal of clinical investigation 118, 2600-2608, doi:10.1172/jci34934 (2008).
41. Ioannidis, J. P., Ntzani, E. E. & Trikalinos, T. A. 'Racial' differences in genetic effects for complex diseases. Nat. Genet. 36, 1312-1318, doi:10.1038/ng1474 (2004).
42. Ji, Y. N., Wang, Q. & Suo, L. J. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis. PLoS One 7, e43397, doi:10.1371/journal.pone.0043397 (2012).
43. Shields, P. G. Molecular epidemiology of smoking and lung cancer. Oncogene 21, 6870-6876 (2002).
44. Wang, J. et al. Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk. PLoS One 7, e47705, doi:10.1371/journal.pone.0047705 (2012).
45. Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008-2012 (2000).
46. Little, J. et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am. J. Epidemiol. 156, 300-310 (2002).
47. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 7, 177-188, doi:10.1016/0197-2456(86)90046-2 (1986).
48. Lau, J., Ioannidis, J. P. & Schmid, C. H. Quantitative synthesis in systematic reviews. Ann. Intern. Med. 127, 820-826 (1997).
49. Higgins, J. P. T. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558, doi:10.1002/sim.1186 (2002).
50. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed.) 315, 629-634 (1997).
51. Harbord, R. M., Egge, M. & Sterne, J. A. C. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat. Med. 25, 3443-3457, doi:10.1002/sim.2380 (2006).
52. Ioannidis, J. P. A. & Trikalinos, T. A. An exploratory test for an excess of significant findings. Clinical Trials 4, 245-253, doi:10.1177/1740774507079441 (2007).
53. Chen, B., Wilkening, S., Drechsel, M. & Hemminki, K. SNP-tools: A compact tool package for analysis and conversion of genotype data for MS-Excel. BMC Res. Notes 2, 214, doi:10.1186/1756-0500-2-214 (2009).